Camrese Kit
FDA Label NDC 0093-3134

45 label sections · Submitted to the FDA by Teva Pharmaceuticals Usa, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Teva Pharmaceuticals Usa, Inc. for the product Camrese (NDC 0093-3134). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: cigarette smoking and serious cardiovascular events, 1 indications and usage, 2.1 how to start and take camrese, 2.2 dosing camrese, 2.3 missed doses, 2.4 advice in case of gastrointestinal disturbances, 3 dosage forms and strengths, 4 contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.